Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Defining and redefining the scope and goals of genetic counseling.

Authors:
Robert G Resta

Am J Med Genet C Semin Med Genet 2006 Nov;142C(4):269-75

Hereditary Cancer Clinic, 1221 Madison #1220, Seattle, WA 98104, USA.

Many definitions of genetic counseling have been proposed since Sheldon Reed first defined the term in 1947. This study reviews selected definitions of genetic counseling including the most recent definition proposed by a committee of the National Society of Genetic Counselors. The analysis focuses on the professional background of who was formulating the definition; the reasons why the definition was created; medical, historical, and social factors; and the definer's implicit or explicit goals of genetic counseling. No definition of genetic counseling is ideal, and any definition can only reflect the values, ethics, goals, and medical practices of the person or group defining the practice of genetic counseling.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.c.30093DOI Listing
November 2006

Publication Analysis

Top Keywords

genetic counseling
24
definitions genetic
8
goals genetic
8
genetic
7
counseling
6
definition
5
created medical
4
definition created
4
reasons definition
4
medical historical
4
historical social
4
factors definer's
4
social factors
4
definition reasons
4
formulating definition
4
counselors analysis
4
focuses professional
4
genetic counselors
4
definer's implicit
4
society genetic
4

Similar Publications

A survey of lifestyle habits, physician counseling, and direct-to consumer genetic testing in patients with hereditary hemochromatosis.

Authors:
Andree H Koop Hassan M Ghoz Fernando F Stancampiano Katie Nordelo William C Palmer

Clin Res Hepatol Gastroenterol 2021 Mar 3:101658. Epub 2021 Mar 3.

Division of Gastroenterology and Hepatology, Mayo Clinic, 500 San Pablo Rd S, Jacksonville, FL 32224, United States. Electronic address:

Introduction And Objectives: The goal of this study was to assess lifestyle habits and physician counseling of patients with hereditary hemochromatosis (HH), and determine the prevalence of direct-to-consumer (DTC) genetic testing.

Materials And Methods: A 52-question survey was created to collect information on lifestyle habits and physician counseling among patients with HH, and the use of DTC genetic testing of patients referred to a clinic for evaluation of HH. A multivariate logistic regression model was applied to identify predictors of DTC genetic testing use. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Clinical delineation, sex differences, and genotype-phenotype correlation in pathogenic KDM6A variants causing X-linked Kabuki syndrome type 2.

Authors:
Víctor Faundes Stephanie Goh Rhoda Akilapa Heidre Bezuidenhout Hans T Bjornsson Lisa Bradley Angela F Brady Elise Brischoux-Boucher Han Brunner Saskia Bulk Natalie Canham Declan Cody Maria Lisa Dentici Maria Cristina Digilio Frances Elmslie Andrew E Fry Harinder Gill Jane Hurst Diana Johnson Sophie Julia Katherine Lachlan Robert Roger Lebel Melissa Byler Eric Gershon Edmond Lemire Maria Gnazzo Francesca Romana Lepri Antonia Marchese Meriel McEntagart Julie McGaughran Seiji Mizuno Nobuhiko Okamoto Claudine Rieubland Jonathan Rodgers Erina Sasaki Emmanuel Scalais Ingrid Scurr Mohnish Suri Ineke van der Burgt Naomichi Matsumoto Noriko Miyake Valérie Benoit Damien Lederer Siddharth Banka

Genet Med 2021 Mar 5. Epub 2021 Mar 5.

Division of Evolution & Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Purpose: The variant spectrum and the phenotype of X-linked Kabuki syndrome type 2 (KS2) are poorly understood.

Methods: Genetic and clinical details of new and published individuals with pathogenic KDM6A variants were compiled and analyzed.

Results: Sixty-one distinct pathogenic KDM6A variants (50 truncating, 11 missense) from 80 patients (34 males, 46 females) were identified. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Diagnostic yield of genetic testing in a heterogeneous cohort of 1376 HCM patients.

Authors:
Julie Hathaway Krista Heliö Inka Saarinen Jonna Tallila Eija H Seppälä Sari Tuupanen Hannu Turpeinen Tiia Kangas-Kontio Jennifer Schleit Johanna Tommiska Ville Kytölä Miko Valori Mikko Muona Johanna Sistonen Massimiliano Gentile Pertteli Salmenperä Samuel Myllykangas Jussi Paananen Tero-Pekka Alastalo Tiina Heliö Juha Koskenvuo

BMC Cardiovasc Disord 2021 Mar 5;21(1):126. Epub 2021 Mar 5.

Blueprint Genetics, a Quest Diagnostics Company, Keilaranta 16 A-B, 02150, Espoo, Finland.

Background: Genetic testing in hypertrophic cardiomyopathy (HCM) is a published guideline-based recommendation. The diagnostic yield of genetic testing and corresponding HCM-associated genes have been largely documented by single center studies and carefully selected patient cohorts. Our goal was to evaluate the diagnostic yield of genetic testing in a heterogeneous cohort of patients with a clinical suspicion of HCM, referred for genetic testing from multiple centers around the world. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Pancytopenia, Recurrent Infection, Poor Wound Healing, Heterotopia of the Brain Probably Associated with A Candidate Novel de Novo Gene Defect: Expanding the Molecular and Phenotypic Spectrum.

Authors:
Abdulaziz Asiri Deemah Alwadaani Muhammad Umair Kheloud M Alhamoudi Mohammed H Almuhanna Abdul Nasir Bahauddeen M Alrfaei Abeer Al Tuwaijri Tlili Barhoumi Yusra Alyafee Bader Almuzzaini Mohammed Aldrees Mariam Ballow Latifah Alayyar Abdulkareem Al Abdulrahman Yazeid Alhaidan Nahlah Al Ghasham Sulaiman Al-Ajaji Mohammad Alsalamah Wafa Al Suwairi Majid Alfadhel

Genes (Basel) 2021 Feb 20;12(2). Epub 2021 Feb 20.

Medical Genomics Research Department, King Abdullah International Medical Research Center (KAIMRC), King Saud Bin Abdulaziz University for Health Sciences, King AbdulAziz Medical City, Ministry of National Guard Health Affairs (MNG-HA), Riyadh 11426, Saudi Arabia.

CDC42 (cell division cycle protein 42) belongs to the Rho GTPase family that is known to control the signaling axis that regulates several cellular functions, including cell cycle progression, migration, and proliferation. However, the functional characterization of the gene in mammalian physiology remains largely unclear. Here, we report the genetic and functional characterization of a non-consanguineous Saudi family with a single affected individual. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Interventions Facilitating Family Communication of Genetic Testing Results and Cascade Screening in Hereditary Breast/Ovarian Cancer or Lynch Syndrome: A Systematic Review and Meta-Analysis.

Authors:
Vasiliki Baroutsou Meghan L Underhill-Blazey Christian Appenzeller-Herzog Maria C Katapodi

Cancers (Basel) 2021 Feb 23;13(4). Epub 2021 Feb 23.

Department of Clinical Research, Faculty of Medicine, University of Basel, 4055 Basel, Switzerland.

Evidence-based guidelines recommend cascade genetic testing of blood relatives of known Hereditary Breast and Ovarian Cancer (HBOC) or Lynch Syndrome (LS) cases, to inform individualized cancer screening and prevention plans. The study identified interventions designed to facilitate family communication of genetic testing results and/or cancer predisposition cascade genetic testing for HBOC and LS. We conducted a systematic review and meta-analysis of randomized trials that assessed intervention efficacy for these two outcomes. Read More

View Article and Full-Text PDF
February 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap